Michael Fischbein

Cardiothoracic surgeon

Women's Heart Health

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-736-0516
Learn More About the Clinic Getting Here Make An Appointment

Center for Marfan Syndrome

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-8246
Learn More About the Clinic Getting Here Make An Appointment

Heart Surgery Clinic

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-724-7500
Learn More About the Clinic Getting Here Make An Appointment

Heart Surgery Clinic at Blake Wilbur Building

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-724-7500
Learn More About the Clinic Getting Here Make An Appointment

Women's Heart Health at Boswell Building

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-736-0516
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Thoracic Surgery, American Board of Thoracic Surgery (2007)

Fellowship: Stanford University Medical Center (2006) CA

Board Certification: General Surgery, American Board of Surgery (2004)

Residency: UCLA School of Medicine (2003) CA

Medical Education: Boston University Medical Center (1995) MA

PhD, University of California, Los Angeles, Microbiology and Immunology (2001)

MD, Boston University School of Medicine, Medicine - Cum Laude (1995)

BS, University of California, Los Angeles, Kinesiology (1990)

Honors & Awards

Donald Morton Research Award, Department of Surgery - UCLA School of Medicine (2003)

Ronald K. Tompkins Golden Apple Teaching Award, UCLA School of Medicine (2003)

Golden Scalpel Award for Teaching Excellence, Division of General Surgery - UCLA School of Medicine (2003)

Caves Scientific Award, International Society for Heart and Lung Transplantation - Osaka, Japan (2000)

Cum Laude Graduate, Boston University School of Medicine (1995)

Alpha Omega Alpha, Boston University School of Medicine (1994)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Hospital & Clinics patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

miR-29b Participates in Early Aneurysm Development in Marfan Syndrome
Merk, D. R., Chin, J. T., Dake, B. A., Maegdefessel, L., Miller, M. O., & Fischbein, M. P. (2012). miR-29b Participates in Early Aneurysm Development in Marfan Syndrome. CIRCULATION RESEARCH, 110(2), 312-?.

Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding.
Sheikh, A. Y., Hill, C. C., Goodnough, L. T., Leung, L. L., & Fischbein, M. P. (2014). Open aortic valve replacement in a patient with Glanzmann's thrombasthenia: a multidisciplinary strategy to minimize perioperative bleeding. Transfusion, 54(2), 300-305.

A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation.
Khatri, P., Roedder, S., Kimura, N., De Vusser, K., Morgan, A. A., & Sarwal, M. M. (2013). A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. journal of experimental medicine, 210(11), 2205-2221.

Tirone David valve-sparing aortic root replacement and cusp repair for bicuspid aortic valve disease
Kari, F. A., Liang, D. H., Kvitting, J.-P. E., Stephens, E. H., Mitchell, R. S., & Miller, D. C. (2013). Tirone David valve-sparing aortic root replacement and cusp repair for bicuspid aortic valve disease. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145(3), S35-?.

David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder
Kvitting, J.-P. E., Kari, F. A., Fischbein, M. P., Liang, D. H., Beraud, A.-S., & Miller, D. C. (2013). David valve-sparing aortic root replacement: Equivalent mid-term outcome for different valve types with or without connective tissue disorder. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 145(1), 117-?.

Bicuspid aortic valve configuration and aortopathy pattern might represent different pathophysiologic substrates
Kari, F. A., Fazel, S. S., Mitchell, R. S., Fischbein, M. P., & Miller, D. C. (2012). Bicuspid aortic valve configuration and aortopathy pattern might represent different pathophysiologic substrates. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144(2), 516-517.

Potential Role of gamma delta T Cell-Derived IL-17 in Acute Cardiac Allograft Rejection
Kimura, N., Nakae, S., Itoh, S., Merk, D. R., Wang, X., & Fischbein, M. P. (2012). Potential Role of gamma delta T Cell-Derived IL-17 in Acute Cardiac Allograft Rejection. ANNALS OF THORACIC SURGERY, 94(2), 542-548.

Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Kodali, S. K., Williams, M. R., Smith, C. R., Svensson, L. G., Webb, J. G., & Leon, M. B. (2012). Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. NEW ENGLAND JOURNAL OF MEDICINE, 366(18), 1686-1695.

Molecular Imaging of Bone Marrow Mononuclear Cell Survival and Homing in Murine Peripheral Artery Disease
van der Bogt, K. Ea., Hellingman, A. A., Lijkwan, M. A., Bos, E.-J., de Vries, M. R., & Wu, J. C. (2012). Molecular Imaging of Bone Marrow Mononuclear Cell Survival and Homing in Murine Peripheral Artery Disease. JACC-CARDIOVASCULAR IMAGING, 5(1), 46-55.

In Vivo Functional and Transcriptional Profiling of Bone Marrow Stem Cells After Transplantation Into Ischemic Myocardium
Sheikh, A. Y., Huber, B. C., Narsinh, K. H., Spin, J. M., van der Bogt, K., & Wu, J. C. (2012). In Vivo Functional and Transcriptional Profiling of Bone Marrow Stem Cells After Transplantation Into Ischemic Myocardium. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 32(1), 92-102.

Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model
Kimura, N., Itoh, S., Nakae, S., Axtell, R. C., Velotta, J. B., & Fischbein, M. P. (2011). Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(12), 1409-1417.

A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection.
Chin, J. T., Troke, J. J., Kimura, N., Itoh, S., Wang, X., & Fischbein, M. P. (2011). A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection. Yale journal of biology and medicine, 84(4), 423-432.

Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion
Itoh, S., Kimura, N., Axtell, R. C., Velotta, J. B., Gong, Y., & Fischbein, M. P. (2011). Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion. CIRCULATION, 124(11), S187-S196.

Prevention of transplant coronary artery disease by prenylation inhibitors
Stein, W., Schrepfer, S., Itoh, S., Kimura, N., Velotta, J., & Fischbein, M. P. (2011). Prevention of transplant coronary artery disease by prenylation inhibitors. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 30(7), 761-769.

alpha B-Crystallin Improves Murine Cardiac Function and Attenuates Apoptosis in Human Endothelial Cells Exposed to Ischemia-Reperfusion
Velotta, J. B., Kimura, N., Chang, S. H., Chung, J., Itoh, S., & Fischbein, M. P. (2011). alpha B-Crystallin Improves Murine Cardiac Function and Attenuates Apoptosis in Human Endothelial Cells Exposed to Ischemia-Reperfusion. ANNALS OF THORACIC SURGERY, 91(6), 1907-1913.

"Peninsula- Style" Transverse Aortic Arch Replacement in Patients With Bicuspid Aortic Valve
Itoh, A., Fischbein, M., Arata, K., & Miller, D. C. (2010). "Peninsula- Style" Transverse Aortic Arch Replacement in Patients With Bicuspid Aortic Valve. ANNALS OF THORACIC SURGERY, 90(4), 1369-1371.

The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice
Itoh, S., Nakae, S., Velotta, J. B., Kosuge, H., Connolly, A., & Fischbein, M. P. (2010). The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(4), 401-409.

IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model
Itoh, S., Nakae, S., Axtell, R. C., Velotta, J. B., Kimura, N., & Fischbein, M. P. (2010). IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model. JOURNAL OF CLINICAL IMMUNOLOGY, 30(2), 235-240.

Long-Term Durability of Open Thoracic and Thoracoabdominal Aneurysm Repair
Fischbein, M. P., & Miller, D. C. (2009). Long-Term Durability of Open Thoracic and Thoracoabdominal Aneurysm Repair. SEMINARS IN VASCULAR SURGERY, 22(2), 74-80.

Comparison of different adult stem cell types for treatment of myocardial ischemia
van der Bogt, K. Ea., Sheikh, A. Y., Schrepfer, S., Hoyt, G., Cao, F., & Wu, J. C. (2008). Comparison of different adult stem cell types for treatment of myocardial ischemia. CIRCULATION, 118(14), S121-U166.

Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease
Schrepfer, S., Deuse, T., Reichenspurner, H., Hoffmann, J., Haddad, M., & Pelletier, M. P. (2007). Effect of inhaled tacrolimus on cellular and humoral rejection to prevent posttransplant obliterative airway disease. AMERICAN JOURNAL OF TRANSPLANTATION, 7(7), 1733-1742.

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
Deuse, T., Schrepfer, S., Reichenspurner, H., Hoyt, G., Fischbein, M. P., & Pelletier, M. P. (2007). Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?. TRANSPLANT IMMUNOLOGY, 17(4), 255-261.

Stem cell transplantation: The lung barrier
Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M. P., Robbins, R. C., & Pelletier, M. P. (2007). Stem cell transplantation: The lung barrier. TRANSPLANTATION PROCEEDINGS, 39(2), 573-576.

Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse, T., Schrepfer, S., Pelletier, M. P., Fischbein, M. P., Robbins, R. C., & Reichenspurner, H. (2007). Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?. TRANSPLANTATION PROCEEDINGS, 39(2), 569-572.